Treatment Information

Back

Non-Hodgkin's Lymphoma treatment details. Chemotherapy.

Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.

Survival: monthsCountry:China
Toxiciy Grade:4City/State/Province:Tianjin
Treatments:ChemotherapyHospital:Tianjin Medical University Cancer Institute and Hospital
Drugs:Journal:Link
Date:Mar 2015

Description:

Patients:
This study involved 49 refractory or relapsed T-Cell lymphoma patients. The median patient age was 50 years and 61.2% were male.

Treatment:
Patients received chemotherapy with gemcitabine, navelbine, and doxorubicin.

Toxicities:
The most severe toxicities were of grade 4 and included grade 3-4 neutropenia and leukopenia. Grade 1-2 nausea and fatigue were also reported.

Results:
The median overall survival was 37 months.

Correspondence: Dr. HuaqingWang; email: huaqingw@163.com



Back